Generalized Myasthenia Gravis
Showing 1 - 25 of 26
Generalized Myasthenia Gravis Trial (rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Nov 28, 2023
Generalized Myasthenia Gravis Trial in Columbia (Whole-body Electrical Muscle Stimulation Exercise)
Active, not recruiting
- Generalized Myasthenia Gravis
- Whole-body Electrical Muscle Stimulation Exercise
-
Columbia, MissouriNextGen Precision Health Building, Clinical Translational Scienc
Sep 26, 2023
Generalized Myasthenia Gravis Trial in Worldwide (Pozelimab + Cemdisiran, Cemdisiran, Placebo)
Recruiting
- Generalized Myasthenia Gravis
- Pozelimab + Cemdisiran
- +3 more
-
Phoenix, Arizona
- +46 more
Jan 31, 2023
Generalized Myasthenia Gravis Trial in Carlsbad (Batoclimab 680 mg SC weekly, Batoclimab 340 mg SC weekly, Matching Placebo SC)
Recruiting
- Generalized Myasthenia Gravis
- Batoclimab 680 mg SC weekly
- +3 more
-
Carlsbad, California
- +14 more
Jan 31, 2023
Generalized Myasthenia Gravis Trial (Efgartigimod IV)
Recruiting
- Generalized Myasthenia Gravis
- Efgartigimod IV
-
Leiden, Netherlands
- +2 more
Jan 16, 2023
Generalized Myasthenia Gravis Trial (Rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Jan 4, 2023
Generalized Myasthenia Gravis Trial in Spain, United States (ALXN1720, Placebo)
Recruiting
- Generalized Myasthenia Gravis
- ALXN1720
- Placebo
-
Gainesville, Georgia
- +7 more
Dec 20, 2022
Generalized Myasthenia Gravis, Myasthenia Gravis Trial in Worldwide (ALXN2050, Placebo)
Recruiting
- Generalized Myasthenia Gravis
- Myasthenia Gravis
- ALXN2050
- Placebo
-
Phoenix, Arizona
- +45 more
Dec 15, 2022
Generalized Myasthenia Gravis, gMG Trial (Ravulizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- gMG
- (no location specified)
Dec 1, 2022
Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))
Not yet recruiting
- Generalized Myasthenia Gravis
- zilucoplan (RA101495)
- (no location specified)
Aug 22, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Satralizumab, Placebo)
Recruiting
- Generalized Myasthenia Gravis
- Satralizumab
- Placebo
-
Scottsdale, Arizona
- +94 more
Aug 16, 2022
Generalized Myasthenia Gravis Trial in Canada, United States (zilucoplan (RA101495), Placebo)
Completed
- Generalized Myasthenia Gravis
- zilucoplan (RA101495)
- Placebo
-
Mobile, Alabama
- +29 more
Jul 26, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab)
Active, not recruiting
- Generalized Myasthenia Gravis
-
Orange, California
- +68 more
Jul 18, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Efgartigimod IV)
Recruiting
- Generalized Myasthenia Gravis
- Efgartigimod IV
-
Wien, Austria
- +12 more
Jul 19, 2022
Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113)
Completed
- Generalized Myasthenia Gravis
- ARGX-113
-
Carlsbad, California
- +51 more
Jul 8, 2022
Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC)
Active, not recruiting
- Generalized Myasthenia Gravis
- efgartigimod PH20 SC
-
Carlsbad, California
- +46 more
Jul 5, 2022
Generalized Myasthenia Gravis Trial in Phoenix (ALXN1830, Placebo)
Withdrawn
- Generalized Myasthenia Gravis
- ALXN1830
- Placebo
-
Phoenix, ArizonaClinical Study Site
Feb 2, 2022
Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113, Placebo)
Completed
- Generalized Myasthenia Gravis
- ARGX-113
- Placebo
-
Phoenix, Arizona
- +65 more
Jan 14, 2022
Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC, efgartigimod IV)
Completed
- Generalized Myasthenia Gravis
- efgartigimod PH20 SC
- efgartigimod IV
-
Carlsbad, California
- +46 more
Jan 31, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab, Placebo)
Completed
- Generalized Myasthenia Gravis
- Rozanolixizumab
- Placebo
-
Phoenix, Arizona
- +91 more
Nov 25, 2021
Generalized Myasthenia Gravis Trial in Worldwide (M281, Placebo)
Generalized Myasthenia Gravis Trial in United States
Recruiting
- Generalized Myasthenia Gravis
-
Phoenix, Arizona
- +9 more
Dec 16, 2020